George M Gould - Net Worth and Insider Trading

George M Gould Net Worth

The estimated net worth of George M Gould is at least $88,920 dollars as of 2025-04-24. George M Gould is the Director of PDL BioPharma Inc and owns about 36,000 shares of PDL BioPharma Inc (PDLI) stock worth over $88,920. Details can be seen in George M Gould's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George M Gould has not made any transactions after 2004-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of George M Gould

To

George M Gould Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George M Gould owns 2 companies in total, including BioSpecifics Technologies Corp (BSTC) , and PDL BioPharma Inc (PDLI) .

Click here to see the complete history of George M Gould’s form 4 insider trades.

Insider Ownership Summary of George M Gould

Ticker Comapny Transaction Date Type of Owner
BSTC BioSpecifics Technologies Corp 2013-09-17 director
PDLI PDL BioPharma Inc 2004-06-30 director

George M Gould Latest Holdings Summary

George M Gould currently owns a total of 1 stock. George M Gould owns 36,000 shares of PDL BioPharma Inc (PDLI) as of May 28, 2004, with a value of $88,920.

Latest Holdings of George M Gould

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDLI PDL BioPharma Inc 2004-05-28 36,000 2.47 88,920

Holding Weightings of George M Gould


George M Gould Form 4 Trading Tracker

According to the SEC Form 4 filings, George M Gould has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 4,000 shares on May 28, 2004, which cost George M Gould around $78,000.

Insider Trading History of George M Gould

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George M Gould Trading Performance

GuruFocus tracks the stock performance after each of George M Gould's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George M Gould is -3.19%. GuruFocus also compares George M Gould's trading performance to market benchmark return within the same time period. The performance of stocks bought by George M Gould within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how George M Gould's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of George M Gould

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.88 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.01 LIMIT LIMIT LIMIT LIMIT LIMIT

George M Gould Ownership Network

Ownership Network List of George M Gould

No Data

Ownership Network Relation of George M Gould

Insider Network Chart

George M Gould Owned Company Details

What does BioSpecifics Technologies Corp do?

Who are the key executives at BioSpecifics Technologies Corp?

George M Gould is the director of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .

BioSpecifics Technologies Corp (BSTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp (BSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp (BSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioSpecifics Technologies Corp (BSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioSpecifics Technologies Corp Insider Transactions

No Available Data

George M Gould Mailing Address

Above is the net worth, insider trading, and ownership report for George M Gould. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, George M Gould's mailing address is: C/o Protine Design Lab 34801 Campus Dr Freemont Ca 94555.